hackint0sh/New-Dataset huggingface dataset:
Crying is usually caused by pain, discomfort, hunger, or separation from parents or other caregivers. Crying carries essential information from birth, the expression of which depends closely on the neuroanatomical and functional brain integrity of the child. On a bioacoustic level, crying consists of sequences of complex acoustic signals produced by the vocal folds and filtered by the vocal tract. The vibration frequency of the vocal cords determines the cry's fundamental frequency f0 (and the harmonic frequencies), which is responsible for its more or less low or high pitch. Other acoustic cues also characterize each baby's cry. conditions: Newborn; Vitality conditions: Premature Infants conditions: Infant Development studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 1100 type: ESTIMATED name: Acoustic signal analysis method measure: Fundamental frequency f0 (Hz) measure: Bailey-4 quantitative scale measure: Percentage voiced frames measure: Harmonics of f0 (Hz) measure: Median pitch f0 (Hz) measure: Harmonicity (dB) measure: Jitter (Percentage), measure: Q25 (Percentage) measure: Median Cepstral Peak Prominence (CPP) (dB) sex: ALL maximumAge: 4 Days stdAges: CHILD facility: Chu de Saint-Etienne status: RECRUITING city: Saint-Étienne zip: 42055 country: France name: Hugues PATURAL, MD-PhD role: PRINCIPAL_INVESTIGATOR lat: 45.43389 lon: 4.39 hasResults: False
nctId: NCT06332508 id: 2022/00406 briefTitle: Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL) overallStatus: RECRUITING date: 2022-12-30 date: 2025-12 date: 2025-12 date: 2024-03-27 date: 2024-03-27 name: National University Hospital, Singapore class: OTHER name: National University of Singapore briefSummary: To assess the safety and tolerability of combined PEMFs and anthracycline-based chemotherapy in subjects who are undergoing neoadjuvant chemotherapy for breast cancer treatment. conditions: Breast Cancer studyType: INTERVENTIONAL phases: PHASE1 allocation: NON_RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 36 type: ESTIMATED name: Pulsed electromagnetic fields (PEMFs) name: Anthracycline-based chemotherapy measure: Incidence of Treatment-Emergent Adverse Events as assessed by CTCAE 5.0 measure: Treatment response as assessed by clinical measurement of tumor size using calipers sex: FEMALE minimumAge: 21 Years maximumAge: 99 Years stdAges: ADULT stdAges: OLDER_ADULT facility: National University Hospital status: RECRUITING city: Singapore zip: 119074 country: Singapore name: Joline Si Jing Lim role: CONTACT phone: 69082222 email: joline_sj_lim@nuhs.edu.sg name: Joline Si Jing Lim role: PRINCIPAL_INVESTIGATOR lat: 1.28967 lon: 103.85007 hasResults: False
nctId: NCT06332495 id: RC23_0573 id: 2024-A00025-42 type: OTHER domain: ANSM (IDRCB) briefTitle: Research Project on the Risk of Discomfort, Pain, Alteration of Skin Condition in Bedpan Use by Patients and Caregivers acronym: RIDAECUBA overallStatus: NOT_YET_RECRUITING date: 2024-06-01 date: 2025-06-01 date: 2025-06-03 date: 2024-03-27 date: 2024-04-22 name: Nantes University Hospital class: OTHER briefSummary: the hypothesis is that the current bedpan is not adapted to the diversity of patients encountered. It is necessary to collect the opinions of patients themselves on the current pool in different departments in order to validate our hypothesis.
The objective is to evaluate pain in patients with reduced or very reduced mobility caused by the bedpan currently used in current practice through an observational study. conditions: Nurse-Patient Relations studyType: OBSERVATIONAL observationalModel: CASE_ONLY timePerspective: PROSPECTIVE count: 300 type: ESTIMATED name: Questioning the patient during hygiene care measure: Assessment of pain in a patient with reduced or very reduced mobility when using a bedpan. measure: Assess the proportion of patients with a MCID of the pain felt by the patient in pre-installation > 1.3 measure: Assess the maximum pain felt by the patient pre/post and per/post use of the bedpan. measure: Assess patient discomfort on the bedpan measure: Assess alteration of skin condition at the seat of the patient using the bedpan measure: Assess the caregiver's pain when handling the bedpan, placing the bedpan in position and removing the bedpan. measure: Assess the risk factors associated with the onset of pain when placing a bedpan. measure: Assess the difficulty of positioning and removing the bedpan. measure: Assess bedpan stability during use measure: Evaluate the effect of time spent on the bedpan on: pain, skin alteration and discomfort sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Nantes University Hospital city: Nantes state: Loire Atlantique zip: 44093 country: France name: Pia SECHER-CAILLETEAU role: CONTACT email: pia.secher@chu-nantes.fr lat: 47.21725 lon: -1.55336 facility: CHU Cholet city: Cholet country: France name: Nelly DIXNEUF role: CONTACT phone: (+33) 2 41 49 69 85 email: nelly.dixneuf@ch-cholet.fr lat: 47.06667 lon: -0.88333 facility: CHU Laval city: Laval country: France name: ROMAIN CHAMPAGNE role: CONTACT phone: (+33) 672091548 email: Romain.CHAMPAGNE@chlaval.fr lat: 48.06667 lon: -0.76667 facility: CH Le Mans city: Le Mans country: France name: Emmanuelle Lecompte role: CONTACT phone: (+33) 681220543 email: gsicot@ch-lemans.fr lat: 48.0 lon: 0.2 facility: CHU Orleans city: Orléans country: France name: Guillaume FOSSAT role: CONTACT phone: (+33) 2 38.65.13.18 email: guillaume.fossat@chu-orleans.fr lat: 47.90289 lon: 1.90389 hasResults: False
nctId: NCT06332482 id: M0303023RP briefTitle: Complete Digital Workflow for Construction of Full Arch Implant Supported Screw Retained Restoration overallStatus: ACTIVE_NOT_RECRUITING date: 2023-03-30 date: 2024-05-20 date: 2024-09-15 date: 2024-03-27 date: 2024-03-27 name: Mansoura University class: OTHER briefSummary: This study will compare the occlusal accuracy of different techniques for recording maxillomandibular relationships in a Complete digital workflow to construct full arch implant-supported screw-retained restoration. conditions: Prosthesis Durability studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: CROSSOVER interventionModelDescription: digital impressions will be made for each patient,3 technique will be used to determine intermaxillary relation. Occlusal prematurties of final prosthesis will compared using occlusense device and all patients will be followed up for one year primaryPurpose: TREATMENT masking: SINGLE whoMasked: PARTICIPANT count: 10 type: ACTUAL name: Implant supported screw retained prosthesis measure: measurement of occlusal prematurity measure: prosthestic complications sex: ALL minimumAge: 45 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Mansoura University ,Faculty of dentistry city: Mansoura zip: P.O.Box:35516 country: Egypt lat: 31.03637 lon: 31.38069 hasResults: False
nctId: NCT06332469 id: INSERT feasibility briefTitle: Evaluation of an Internet Based Education and Support Program for Patients Awaiting Kidney Transplantation acronym: INSERT overallStatus: NOT_YET_RECRUITING date: 2024-04-08 date: 2025-10-31 date: 2025-10-31 date: 2024-03-27 date: 2024-03-27 name: Linkoeping University class: OTHER_GOV briefSummary: The goal of this study is to test the feasibility study of an internet based education and support program for patients awaiting kidney transplantation. The study is designed as a national pilot randomized controlled trial with a waitlist control group, to test the feasibility, acceptability, and potential effects of the intervention on patients' physical and mental health. conditions: Chronic Kidney Diseases studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: The intervention group gets immediate access to the 9 week program, and the waitlist control group gets access after a 9 week waiting period. primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 80 type: ESTIMATED name: Internet based education and support program for patients awaiting kidney transplantation measure: Kidney transplant understanding tool (K-TUT) measure: Self-care in chronic illness inventory v.4c measure: The Self-Efficacy for Managing Chronic Disease 6-item Scale (SES6G measure: Pearlin Mastery Scale measure: The Depression Anxiety Stress Scales 21 (DASS-21) measure: Acceptance of chronic health conditions scale (ACHC) measure: EQ-5D-5L sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06332456 id: ICM 2023-3169 briefTitle: Assessment of Renal Microcirculation With Rubidium Positron Emission Tomography acronym: RESIST overallStatus: RECRUITING date: 2023-07-04 date: 2024-12 date: 2024-12 date: 2024-03-27 date: 2024-03-27 name: Matthieu Pelletier-Galarneau, MD MSc class: OTHER briefSummary: The aim of this study is to demonstrate that positron emission tomography imaging with Rubidium-82 (radioactive tracer) can non-invasively detect and quantify changes in renal blood flow (renal perfusion) and renal vascular resistance in both healthy subjects and patients with renal insufficiency. Ultimately, the results of this study will contribute to a better understanding of the role of positron emission imaging in the evaluation of patients with renal diseases. conditions: Renal Microcirculation With Rubidium Positron Emission Tomography studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: PROSPECTIVE count: 30 type: ESTIMATED measure: Renal blood flow in units of mL/min/100g measure: Renal vascular resistance in units of mmHg/mL/min/100g measure: Correlation between renal vascular resistance measured with PET and measured with echography measure: Coefficient of repeatability of renal blood flow sex: ALL minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Montreal Heart Institute status: RECRUITING city: Montréal state: Quebec zip: H1T 1C8 country: Canada name: Matthieu Pelletier-Galarneau role: CONTACT phone: 5143763330 phoneExt: 4418 email: matthieu.pelletier-galarneau@icm-mhi.org lat: 45.50884 lon: -73.58781 hasResults: False
nctId: NCT06332430 id: CW-202 briefTitle: Intratumoral CAN2109 in Subjects With Solid Tumors or Lymphomas overallStatus: NOT_YET_RECRUITING date: 2024-05-30 date: 2025-05-30 date: 2026-05-30 date: 2024-03-27 date: 2024-03-27 name: Canwell Biotech Limited class: INDUSTRY briefSummary: A phase 1, dose escalation, open-label study of intratumoral CAN2109 in subjects with unstable or metastatic advanced solid tumors or lymphomas. conditions: Solid Tumor conditions: Lymphoma studyType: INTERVENTIONAL phases: PHASE1 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 27 type: ESTIMATED name: CAN2109 measure: Safety and tolerability measure: Recommended Phase 2 Dose (RP2D) measure: To determine the efficacy of CAN2109 measure: To evaluate the pharmacodynamics of CAN2109 sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Sun Yat-Sen University Sun Yat-Sen Memorial Hospital city: Guangzhou state: Guangdong zip: 510535 country: China lat: 23.11667 lon: 113.25 hasResults: False
nctId: NCT06332417 id: REC/RCR&AHS/23/0364 briefTitle: Combined Effects of Ba-Duan-Jin Based Deep Breathing Exercises and Forced Expiratory Technique overallStatus: RECRUITING date: 2024-02-29 date: 2024-06-05 date: 2024-06-15 date: 2024-03-27 date: 2024-03-27 name: Riphah International University class: OTHER briefSummary: This study will be a randomized control trial. A total of 68 patients will be recruited and randomly assign to the experimental group or the control group in a 1:1 ratio. Participants in the experimental group will receive a 8-week Ba-duan jin exercise training intervention along with Forced Expiratory Technique at least 3 days a week and 30 minutes a day, while participants in the control group will be only given Forced Expiratory intervention and will be told to maintain their original lifestyle for 8 weeks along with standard COPD treatment. conditions: Chronic Obstructive Pulmonary Disease studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 68 type: ESTIMATED name: Ba-Duan-Jin Based Deep Breathing Exercises name: FET (Forced Expiratory Technique) measure: 36-Item Short Form Survey (SF-36) measure: FEV1/FVC ratio measure: Exercise Tolerance : 6 minute walk test measure: Forced vital capacity (FVC) measure: Forced expiratory volume (FEV1) sex: ALL minimumAge: 40 Years maximumAge: 55 Years stdAges: ADULT facility: Social Security Teaching Hospital status: RECRUITING city: Lahore state: Punhab zip: 42000 country: Pakistan name: Faisal Rehman, MBBS role: CONTACT phone: +924299230227 email: info@pessi.punjab.gov.pk lat: 31.558 lon: 74.35071 hasResults: False
nctId: NCT06332404 id: B3002024000047 briefTitle: Hypoglossal Nerve Stimulation Therapy in Patients With Obstructive Sleep Apnea: Belgian Registry acronym: B-HNS overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2034-04 date: 2034-04 date: 2024-03-27 date: 2024-03-27 name: University Hospital, Antwerp class: OTHER briefSummary: Hypoglossal nerve stimulation (HNS) therapy (Inspire system) is intended for the treatment of patients with moderate to severe obstructive sleep apnea (OSA) who cannot be effectively treated with the first-line treatment options. Recently, the request for reimbursement of the Inspire system in Belgium was approved.
The aim is to create a registry of OSA patients that are treated with HNS (Inspire system) within routine clinical care at the Antwerp University Hospital. conditions: Obstructive Sleep Apnea conditions: Sleep Apnea conditions: Apnea studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 225 type: ESTIMATED name: Hypoglossal nerve stimulation Inspire system (Inspire Medical Systems Inc., USA) measure: Delta apnea-hypopnea index (AHI) as measured by a polysomnography measure: % of patients that reach treatment success defined by a 50% reduction in AHI and an on therapy AHI of < 20 events/h OR an on therapy AHI of < 15 events/h measure: Therapy adherence defined by the amount of hours therapy usage per night. measure: Delta oxygen desaturation index (ODI) as measured by a polysomnography measure: Daytime sleepiness measured by the Epworth Sleepiness Scale (ESS) questionnaire measure: Disease-specific quality of life as measured by the Functional Outcomes of Sleep Questionnaire-30 (FOSQ-30) questionnaire measure: Degree of snoring measured by the Visual Analogue Scale (VAS) questionnaire sex: ALL minimumAge: 18 Years maximumAge: 99 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Antwerp University Hospital city: Edegem state: Antwerp zip: 2650 country: Belgium name: Dorine Van Loo, Msc role: CONTACT phone: +3238215780 email: dorine.vanloo@uza.be name: Olivier Vanderveken, MD, PhD role: PRINCIPAL_INVESTIGATOR lat: 51.15662 lon: 4.44504 hasResults: False
nctId: NCT06332378 id: sHasan briefTitle: Effect of Exercise Therapy on Type II Diabetic Neuropathic Patients overallStatus: NOT_YET_RECRUITING date: 2024-04-02 date: 2024-08-15 date: 2024-08-15 date: 2024-03-27 date: 2024-03-27 name: Dr. Sobia Hasan class: OTHER briefSummary: The goal of this Randomized control trial (clinical trial) is to learn about the effect of Exercise therapy on Type II Diabetic Neuropathic Patient in Pakistan ,40-70 year's old patient, will be refer by physicians.
Exclusion criteria of the study will lower extremity complications such as fracture, having experience dislocation at least six months prior to the study, having any history of surgical operations in muscles, bones, and joints of lower extremities, suffering from musculoskeletal disorders such as rheumatoid arthritis and myopathy, middle ear and vestibular impairments (patients' self-report), knee joint flexion contracture, and interruption of the intervention sessions for more than two days..
Each exercise session contain 5 min warm-up (stationary bike), 45 min exercise training (with 1 minute rest for every 5 minutes of exercise), and 5 min of cool down activities including stretching of the muscles involved in balance exercise (gluteal, erector spine, hamstring, rectus femorus, gastro soleus, and pectoral muscles). This make the participants' heart rate stable and prepare their muscles for optimal activity. conditions: Diabetic Neuropathies studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 90 type: ESTIMATED name: Experimental group 1 :Ball training name: Experimental group 2 :Frenkel Exercises name: Control Group measure: One Leg Stance measure: Berg Balance Scale measure: Timed Up and Go Test: measure: Diabetic Neuropathy Symptom Score measure: Hemoglobin A1C sex: ALL minimumAge: 40 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06332365 id: ID: 3938/2022 briefTitle: Evaluating Treatment Efficacy in Oral Lichen Planus: The Role of Salivary Biomarkers acronym: salivaLichen overallStatus: COMPLETED date: 2022-01-03 date: 2023-12-15 date: 2024-02-19 date: 2024-03-27 date: 2024-03-27 name: Pia Lopez Jornet class: OTHER briefSummary: Lichen planus, a chronic autoimmune mucocutaneous disorder, affects 0.5% to 2.2% of diverse populations. The treatment for oral lichen planus (OLP) includes a range of options, both topical and systemic therapies. Recent research has highlighted the potential of hyaluronic acid as a drug alternative, potentially offering effective management for OLP and alleviating the discomfort of this chronic condition. The objective was to assess the impact of topical hyaluronic acid on salivary oxidative stress markers in individuals suffering from oral lichen planus conditions: Oral Lichen Planus conditions: Oral Lichen Planus Related Stress studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE maskingDescription: Randomization: The enrolled subjects were randomly assigned to one of two treatment protocols using a computer-generated table. This method ensures impartial allocation and avoids biases in treatment selection for each patient.
Masking: Medications were prepared and packaged in identical, sealed, and numbered envelopes by the hospital pharmacy and a clinician not involved in the subsequent phases of the study. Each sealed envelope contained the protocol assignment for individual patients and written instructions for the application of the medications. Moreover, clinicians involved in treatment evaluation at each follow-up session were blinded to the treatment assigned to each patient. whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 60 type: ACTUAL name: Acetonide triamcinolone 0.2% +hyaluronicacid 1% name: Corticoid Acetonide triamcinolone 0.2% name: Hyaluronic acid 1% measure: Pain assessment scale measure: OHIP-14 questionnaire measure: reduction of clinical signs measure measure: Salivary level of oxidative stress biomarker sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Pia Lopez Jornet city: Murcia zip: 30004 country: Spain lat: 37.98704 lon: -1.13004 hasResults: False
nctId: NCT06332352 id: 00173470 briefTitle: Intra-articular Platelet-Rich Plasma for Acetabular Labral Tears acronym: PRP for ALT overallStatus: RECRUITING date: 2024-01-25 date: 2025-01-25 date: 2026-01-25 date: 2024-03-27 date: 2024-03-27 name: University of Utah class: OTHER briefSummary: Platelets are small cells found in the blood that help form clots and stop bleeding. Platelet-rich plasma is blood that contains more platelets than normal and can be given to help people with pain. Tears of the Labrum to the hip (the cartilage "suction cup" that holds the ball to the socket of the hip) cause hip pain. The study wants to see if a portion of the patient's blood, the platelets, will help relieve hip pain and function.
Participation requires completing surveys by email, text message, in person, and/or by telephone. Medical tests will also be done to track the health of participants. conditions: Acetabular Labrum Tear studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 30 type: ESTIMATED name: PRP measure: Pain & Function Improvements measure: Visual Analog Scale (VAS) measure: Harris Hip Scores (HHS) measure: International Hip Outcome Tool (iHOT-12) measure: EQ-5D (EuroQual 5D) sex: ALL minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT facility: University of Utah - Department of Orthopaedics status: RECRUITING city: Salt Lake City state: Utah zip: 84108 country: United States name: Luke A Johnson, BS role: CONTACT phone: 801-213-3379 email: luke.a.johnson@utah.edu name: Daniel Cushman, MD role: PRINCIPAL_INVESTIGATOR name: Derek Stokes, MD role: SUB_INVESTIGATOR lat: 40.76078 lon: -111.89105 hasResults: False
nctId: NCT06332339 id: HVTN 313 briefTitle: Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of 16055 NFL Delta Gly4 Env Protein Trimer and Trimer 4571 Combined With 3M-052-AF + Alum Adjuvant and Ad4-Env145NFL Viral Particles as Heterologous Prime-boost Regimens in Adult Participants Without HIV. overallStatus: RECRUITING date: 2024-04-10 date: 2026-11-11 date: 2026-11-11 date: 2024-03-27 date: 2024-04-03 name: National Institute of Allergy and Infectious Diseases (NIAID) class: NIH briefSummary: The goal of this clinical trial is to test 16055 NFL delta Gly4 Env protein trimer and Trimer 4571 combined with 3M-052-AF + Alum adjuvant and Ad4-Env145NFL viral particles as heterologous prime-boost regimens in adult participants without HIV.
nctId: NCT06332326 id: E-10840098-772.02-4966 briefTitle: Investigation of the Efficacy of Non-Invasive Vagus Nerve Stimulation and Physiotherapy in Unilateral Vestibular Hypofunction Patients overallStatus: RECRUITING date: 2022-10-23 date: 2024-04 date: 2024-05 date: 2024-03-27 date: 2024-03-27 name: Medipol University class: OTHER briefSummary: The purpose of this study: To investigate the effectiveness of non-invasive vagus nerve stimulation and vestibular rehabilitation applications in patients diagnosed with Unilateral Vestibular Hypofunction (UVH). conditions: Vestibular Diseases conditions: Vestibular Vertigo conditions: Vertigo studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: 40 patients diagnosed with UHV were included. Patients were randomized into 2 separate groups (20 people in the vestibular rehabilitation group, 20 people in the vagus nerve stimulation group in addition to vestibular rehabilitation). primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 40 type: ESTIMATED name: non-invasive vagus nerve stimulation name: vestibular rehabilitation measure: Modified-CTSIB measure: Semitandem test measure: tandem test measure: one-leg standing test measure: Unterberger test measure: VAS Visual Analogue Scale (dizziness severity) measure: Dynamic visual acuity test measure: Dizziness Handicap Inventory Scale measure: Tampa Kinesiophobia Scale measure: Hospital Anxiety and Depression Scale (HAD) sex: ALL minimumAge: 18 Years maximumAge: 50 Years stdAges: ADULT facility: Istanbul Medipol University status: RECRUITING city: Istanbul country: Turkey name: tuğba türk kalkan, MD role: CONTACT phone: +905334956459 email: tugbatrkk@gmail.com name: tugba türk kalkan, MD role: PRINCIPAL_INVESTIGATOR lat: 41.01384 lon: 28.94966 hasResults: False